Insiders Trades
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Mar 2026 for Cumberland Pharmaceuticals INC, €4,368. Read the official filing
Filing timeline
BuySaleKenneth Krogulski
Insider track record
Disclosed buys
23
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+20.2%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Kenneth Krogulski: trading record in brief
All filings by Kenneth Krogulski on record concern Cumberland Pharmaceuticals Inc, in the capacity of board member. The record holds 47 filings, for trades running from 17 March 2021 to 18 March 2026.
Purchases make up the whole of the open-market record (23 purchases, €5,889). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants.
The median purchase comes to €239. On 23 out of 23 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 20 March 2026: a share grant of €4,368, in Cumberland Pharmaceuticals Inc. The clock since the last published purchase (12 September 2025) now reads 401 days. Typically, a trade is published a median of 32 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kenneth Krogulski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
1,800 shares@ US$2.808.4% of flowCommon StockSEC:0001087294-26-000037:0
124 shares@ US$2.360.5% of flowCommon StockSEC:0001087294-26-000002:0
68 shares@ US$2.800.3% of flowCommon StockSEC:0001087294-25-000025:0
68 shares@ US$3.310.4% of flowCommon StockSEC:0001695580-25-000004:0
62 shares@ US$3.540.4% of flowCommon StockSEC:0001087294-25-000006:0
68 shares@ US$3.440.4% of flowCommon StockSEC:0001628280-25-041983:0
Canonical exit: 30 Oct 2025 (T+90)
80 shares@ US$3.560.5% of flowCommon StockSEC:0001628280-25-039397:0
Canonical exit: 29 Sept 2025 (T+90)
45 shares@ US$5.200.4% of flowCommon StockSEC:0001628280-25-034814:0
Canonical exit: 31 Aug 2025 (T+90)
45 shares@ US$4.860.4% of flowCommon StockSEC:0001628280-25-029856:0
Canonical exit: 30 Jul 2025 (T+90)
45 shares@ US$4.240.3% of flowCommon StockSEC:0001628280-25-024346:0
Canonical exit: 30 Jun 2025 (T+90)
47 shares@ US$5.540.5% of flowCommon StockSEC:0001628280-25-016741:0
Canonical exit: 1 Jun 2025 (T+90)
1,000 shares@ US$5.179.2% of flowCommon StockSEC:0001628280-25-013546:0
6,500 shares@ US$1.7120.0% of flowCommon StockSEC:0001628280-25-003183:0
415 shares@ US$1.331.0% of flowCommon StockSEC:0001628280-24-052603:0
Canonical exit: 2 Mar 2025 (T+90)
380 shares@ US$1.150.8% of flowCommon StockSEC:0001628280-24-050104:0
Canonical exit: 30 Jan 2025 (T+90)
309 shares@ US$1.270.7% of flowCommon StockSEC:0001628280-24-045328:0
Canonical exit: 30 Dec 2024 (T+90)
250 shares@ US$1.380.6% of flowCommon StockSEC:0001628280-24-042110:0
221 shares@ US$1.470.6% of flowCommon StockSEC:0001214659-24-016036:0
221 shares@ US$1.470.6% of flowCommon StockSEC:0001214659-24-013691:0
134 shares@ US$1.520.4% of flowCommon StockSEC:0001214659-24-011871:0
5,000 shares@ US$1.7115.4% of flowCommon StockSEC:0001214659-24-005226:0
379 shares@ US$1.691.1% of flowCommon StockSEC:0001214659-23-017030:0
66 shares@ US$1.730.2% of flowCommon StockSEC:0001214659-23-016097:0
280 shares@ US$1.851.0% of flowCommon StockSEC:0001214659-23-015351:0
280 shares@ US$2.241.2% of flowCommon StockSEC:0001214659-23-014538:0
25 of 47 declarations
